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Abstract
Introduction. Ankylosing spondylitis (AS) is a chronic inflammatory disease with an unknown etiology that belongs to 
the group of spondyloarthropathies. Patients with AS have an increased cardiovascular mortality but the reason is 
controversial. Central aortic pressure (CAP) is defined as the blood pressure in the aortic root and can be measured 
non-invasively via arteriography. Inflammation in the aortic root, which also causes aortic regurgitation in late stages 
of AS, possibly causes increased levels of central aortic pressure and this may explain the increased mortality rates 
from cardiovascular events in patients with AS. We investigated the CAP levels in patients with AS compared to healthy 
age- and sex-matched control group in this novel study.
Material and methods. This is an observational case-control study composed of 30 patients with ankylosing spondylitis 
without conventional cardiovascular risk factors (such as known diabetes, hypertension, and smoking) or heart failure, 
peripheral or coronary artery disease. The peripheral blood pressures and CAP measurements were obtained with ‘ar-
teriograph’ (TensioMed, Budapest, Hungary).Pulse wave velocity (PWV), peripheral and central augmentation index (pAIx 
and cAIx) and systolic central aortic pressure (sCAP) of both the AS and control group were compared.
Results. There was no statistically significant difference between the groups for pAIx, cAIx, PWV or PP. Patient with AS 
had higher sCAP values but there wasn’t any statistically significant difference for sCAP.
Conclusion. Our objective was to investigate the relationship between the AS and sCAP. There was an increase in sCAP 
in AS group compared to controls. But this was not statistically significant. This result can be due to the small population 
size and should be verified in larger population.
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Introduction
Ankylosing spondylitis (AS) is a chronic inflammatory dise-
ase with an unknown etiology that belongs to the group 
of spondyloarthropathies (SpA). Patients with AS have 
an increased cardiovascular mortality [1]. The reason is 
controversial but it has been explained by increased cardio-
vascular risk factors in those patient group, inflammation, 
the non-steroid anti-inflammatory drugs (NSAIDs) or other 
drugs they have been taking that effect myocardium [2].
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Sclerosing inflammation (aortitis) in AS can effect aortic 
root and aortic valves and causes aortic regurgitation [3]. 
Aortic regurgitation is seen in 6–10% of all patients [4].
Central aortic pressure (CAP) is defined as the blood 
pressure in the aortic root. CAP is superior to peripheral 
arterial pressure for the prediction of cardiovascular 
events [5–7]. CAP can be measured by pressure sensors 
directly from the aorta or by catheters. Because this 
method is invasive and has the potential of complication, 
it is not used in daily practice. But CAP can be measured 
by the brachial cuff that can calculate pulse waves with 
software. These tools can provide measurements of CAP 
that are not different from those obtained with invasive 
methods [6].
According to our prespecified hypothesis this inflamma-
tion in the aortic root possibly causes increased levels of 
central aortic pressure and this may explain the increased 
mortality rates from cardiovascular events in patients with 
AS. The aim of this novel study is to investigate the CAP 
levels in patients with AS without conventional risk factors 
for atherosclerosis (hypertension, diabetes mellitus, smok-
ing) or heart failure, peripheral/coronary artery disease, 
compared to healthy age and sex matched control group. 
This article is written according to the STROBE statement 
checklist for case-control studies.
Materials and methods
This study was approved by the ethical committee of Afyon 
Kocatepe University Hospital. Informed consent was taken 
from all patients and controls.
This was an observational case-control study composed 
of 30 patients with ankylosing spondylitis (mean age: 
35.5 ± 12.1) without conventional cardiovascular risk fac-
tors (such as known diabetes, hypertension, and smoking) 
or heart failure, peripheral or coronary artery disease who 
were treated at the Afyon Kocatepe University Hospital, 
Department of Physical Therapy and Rehabilitation and 
Department of Cardiology compared with 30 healthy sub-
jects (mean age: 34.9 ± 12.9) with similar age and sex.
The patients were recruited between May 2014 and 
November 2015. The patients had been previously diag-
nosed with AS in the physical therapy and rehabilitation 
clinic with modified New York Criteria [8]. The past medical 
history data of the patients were confirmed based on pre-
vious patient records and laboratory results. The previous 
laboratory data were also investigated to rule out diabetes/ 
/impaired fasting glucose or lipid profile disorders. Because 
CRP and/or erythrocyte sedimentation rate are accepted as 
risk factors, patients with elevated CRP and/or erythrocyte 
sedimentation rate were not accepted to the study [9]. 
Also, because TNF-alfa inhibitors can affect target organ 
damage [10], patients on TNF-alfa inhibitors were excluded 
from the study. Inclusion and exclusion criteria of patients 
are listed in Table 1.
The echocardiographic evaluation consisted of M-mode, 
2-D and colored Doppler echocardiographic evaluation 
completed by one echocardiographer. Parasternal long axis, 
parasternal short axis and apical four chamber views were 
obtained. Philips HD 1 XE (Germany, 2008) echocardiogra-
phy tool with 3.5 MHz transducer was used for the study.
The peripheral blood pressures and CAP measurements 
were obtained with ‘arteriograph’ (TensioMed, Budapest, 
Hungary). This tool consists of a brachial cuff that measures 
the brachial peripheral arterial pressures automatically. It 
drops the pressure of the cuff to measure pulse waves and 
can define dicrotic notch and transmits the findings to the 
computer by infrared waves. We measured the true aortic 
length (estimated by the jugulum–symphysis distance) of 
the subjects by tape and enable the value to the software. 
Then, the software of the device calculated pulse wave 
velocity (PWV), peripheral and central augmentation index 
(pAIx and cAIx) and systolic central aortic pressure (sCAP). 
The patients were warned about not drinking coffee or tea 
before the measurement and they rested for 5 minutes 
in a quiet room. All measurements were completed while 
patients were lying in supine position.
The data obtained in the study were analyzed with SPSS 
(Statistical Package for Social Sciences for Windows) for 
statistical evaluation. Categorical variables are shown as 
percentage. Kolmogorov-Smirnov test was used to check 
whether those variables fit to normal distribution or not. 
The difference between the groups of variables with normal 
distribution was calculated with t-test and the difference 
between the groups of variables that did not fit to normal 
distribution was calculated with Mann-Whitney U test. The 
results are shown in 95% confidence interval and signifi-
cance is accepted as p < 0.05.
Table 1. Inclusion and exclusion criteria
Inclusion criteria for the patient group
1. Patients with ankylosing spondylitis, diagnosed according  
     to modified New York Criteria
2. Patients older than 18 years
Exclusion criteria for the patient group
1. Patients with chronic hypertension
2. Patients with known diabetes 
3. Patients with known coronary artery disease
4. Patients with known peripheral artery disease 
5. Patients with heart failure
6. Smokers
7. Patients with increased CRP/sedimentation rate
8. Patients on TNF-alfa inhibitors
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Results
Thirty patients with AS and 30 healthy subjects were re-
cruited for the study. The demographic and clinical char-
acteristics of the study groups are shown in Table 2. There 
was no statistical difference between the groups for age, 
sex, body mass index (BMI), systolic or diastolic pressures. 
But there was statistical difference for heart rate and mean 
arterial pressure (p = 0.01 and p = 0.022, respectively).
The M-mode, 2D echocardiographic parameters of the 
patient and control group were within normal limits. The 
echocardiographic values are shown in Table 3. Also 2 pa-
tients in the patient group had mild aortic regurgitation.
Arterial stiffness parameters were evaluated and there 
was no statistically significant difference between the 
groups for pAIx, cAIx, PWV or PP. Patients with AS had higher 
sCAP values but there wasn’t any statistically significant 
difference for sCAP (Table 4).
Table 2. The demographic and clinical characteristics of the study groups
Variables Patient 
(n = 30)
Control 
(n = 30)
p
Age [years] 35.5 ± 12.15 34.9 ± 12.91 0.06
Height [cm] 168.5 ± 7.71 171.9 ± 8.12 0.09
Weight [kg] 76.5 ± 12.59 74.6 ± 11.40 0.57
Body mass ındex [kg/m2] 26.95 ± 4.81 25.15 ± 3.32 0.10
Systolic blood pressure [mm Hg] 132.1 
(171–108)
122 
(111–162)
0.60
Diastolic blood pressure [mm Hg] 81.2 ± 9.60 76.4 ± 9.0 0.052
Mean arterial blood pressure [mm Hg] 97.5 
(83–122)
90.5 
(75–121)
0.022
Heart rate [beat/min] 78.90 ± 11.70 70.10 ± 7.50 0.01
Table 3. The echocardiographic values in the patient and control groups
Variables Patient 
(n = 30)
Control 
(n = 30)
p
Left ventricle diastolic diameter [mm] 44.4 ± 6.8 43.2 ± 6.7 0.069
Left ventricle systolic diameter [mm] 24.2 ± 4.2 24.1 ± 4.8 0.133
Ejection fraction [%] 61 ± 5.4 60.1 ± 6.2 0.070
Interventricular septum diameter [mm] 10.4 ± 1.7 10.1 ± 1.6 0.112
Posterior wall diameter [mm] 10.3 ± 1.8 10.2 ± 1.9 0.114
Left atrium length [mm] 38.7 ± 2.2 38.2 ± 2.1 0.151
Aortic root diameter [mm] 29.8 ± 3.5 30.1 ± 3.4 0.092
Table 4. Arterial stiffness parameters in the patient and control groups
Variables Patient 
(n = 30)
Control 
(n = 30)
p
Pulse pressure [mm Hg] 50.5 (35-48) 46 (36–81) 0.52
Peripheral augmentation ındex –53.7 
(–80.9–25.1)
–61.75 
(–84.1–25.2)
0.42
Central augmentation ındex 10.45 
(–3.3–50.3)
6.35 
(–5–50.4)
0.37
Pulse wave velocity [m/s] 7.5 ± 1.2 7.3 ± 1.4 0.64
Systolic central aortic pressure [mm Hg] 116.35 
(97.3–166)
107.95 
(90–161.7)
0.056
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Streszczenie
Wstęp. Zesztywniające zapalenie stawów kręgosłupa (AS) to przewlekła choroba zapalna o nieznanej etiologii należąca 
do spondyloartropatii. U chorych z AS obserwuje się zwiększoną śmiertelność sercowo-naczyniową, jednak przyczyny 
tego zjawiska nie są znane. Ciśnienie centralne w aorcie (CAP) jest definiowane jako ciśnienie krwi w korzeniu aorty. 
Możliwy jest nieinwazyjny pomiar CAP metodą arteriografii. Zapalenie w obrębie korzenia aorty, będące również przyczy-
ną niedomykalności w późnym stadium AS, może powodować wzrost ciśnienia centralnego w aorcie, co może tłumaczyć 
zwiększoną śmiertelność z powodu zdarzeń sercowo-naczyniowych w grupie chorych z AS. Autorzy zbadali wartości CAP 
u chorych z AS w porównaniu z wartościami uzyskanymi w grupie kontrolnej złożonej ze zdrowych osób dobranych pod 
względem wieku i płci.
Discussion
Coronary artery disease is the leading cause of death and 
unfortunately there is no effective single test to screen 
patients before the symptoms onset. So the risk factors 
for coronary artery disease are very important to diagnose 
patients. Patients with AS have an increased cardiovascular 
mortality rate. But the cause or the mechanism cannot be 
perfectly explained. It is also important because the cardio-
logists still cannot be sure whether to screen patients with 
AS for possible future cardiac events, except valvular heart 
disease. Should they screen asymptomatic AS patients for 
coronary artery disease?
Our objective was to investigate the relationship be-
tween the AS and sCAP. There was an increase in sCAP in 
AS group compared to controls. But this was not statistically 
significant. This result can be due to the small population 
size and should be verified in larger population.
Also our prespecified hypothesis was the inflam-
mation in aortic root in patients with AS can cause an 
increased CAP. And the increased CAP may explain the 
increased cardiovascular mortality in patients with AS. 
The aortic regurgitation is usually a late sign in patients 
with AS and it is due to the inflammation/aortitis [3]. But 
our population consisted of AS patients without moderate 
or severe aortic regurgitation. So it is possible to con-
clude that the inflammation in aorta of our AS population 
wasn’t severe. It might be possible to find a significant 
increase in CAP in patients with AS compared to controls, 
if this study was designed with a larger population. It will 
also be vise to divide the AS group at least at 2 as with 
moderate/severe aortic regurgitation and normal/mild 
aortic regurgitation.
Similar studies also showed increased arterial stiff-
ness parameters. We investigated PWV, AIx and PP. But 
there wasn’t any increase in arterial stiffness. This can 
be explained in two different ways. One of the hypothesis 
to explain the increased cardiovascular mortality was the 
increased risk factors in patients with AS. Our study popu-
lation consisted of patients without known cardiovascular 
risk factors. The first possible explanation for not finding 
a significant difference for arterial stiffness parameters 
in this study is the fact that the AS group population was 
chosen from patients without known cardiovascular risk 
factors. The second explanation for not finding a significant 
difference for arterial stiffness parameters in this study is 
limited sample size.
On the other hand, the study group was relatively young 
for AS, which is mostly seen in the third decade of life. So 
it can be stated that the study group consisted of patients 
with short disease duration and eventually short time to 
cause target organ damage. Considering the results of 
the arterial stiffness, parameters were not significantly 
different in both groups and the short disease duration may 
not be enough to cause target organ damage. So, a long 
term follow-up study design will be needed to show which 
arterial stiffness parameter is changing first. If the CAP is 
worsening first, it can be stated that the aortic inflammation 
is the beginning of the cardiovascular problems.
Overall, our study did not show a relationship between 
AS and increased sCAP. But this idea was never evaluated 
before and insignificant increase in CAP in patients with 
AS is still important for future studies. We believe it could 
explain a very important mechanism for increased cardio-
vascular mortality in patients with AS but the study should 
be designed with larger population.
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